LONG BEACH, Calif. — Clinicians do not consistently use algorithms for dosing methoxy polyethylene glycol-epoetin beta when treating patients with anemia, presented research shows.
“Multiple dosing algorithms exist for the use of [methoxy polyethylene glycol-epoetin beta] MPG-EPO [Mircera, Vifor Pharma],” Namrata Shrestha, MD, of the University of the Incarnate Word, San

Related Keywords

Texas , United States , San Antonio , Gina Brockenbrough , Bymarke Neumann , Namrata Shrestha , Renal Associates , University Of The Incarnate Word , National Kidney Foundation Spring Clinical Meetings , Incarnate Word , National Kidney Foundation Spring Clinical ,